The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIL0A.L Regulatory News (IL0A)

  • There is currently no data for IL0A

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

20 Apr 2016 16:00

RNS Number : 8273V
Permanent TSB Group Holdings PLC
20 April 2016
 

PERMANENT TSB GROUP HOLDINGS PLC

 

Result of Annual General Meeting (AGM)

 

 

The directors of the Company wish to announce that each of the resolutions proposed at the AGM of the Company held on Wednesday 20 April 2016 were passed. The full text of each resolution was included in the notice of the AGM circulated to shareholders on 18 March 2016.

 

A summary of poll results for this meeting will shortly be available on the Company's website at:

 

http://www.permanenttsbgroup.ie/investors/shareholder-services/annual-general-meeting/2016.aspx

 

In accordance with the Irish listing rule 6.6.3 the full text of all resolutions (other than resolutions concerning ordinary business) passed by the meeting are set out below:

 

Resolution 5

To consider and, if thought fit, to pass the following as an ordinary resolution:

 

The aggregate ordinary remuneration of the Directors (for serving as Directors of the Company) shall be an amount not exceeding €500,000 as they may from time to time determine in accordance with the articles of association of the Company for the time being.

 

Resolution 6

To consider and, if thought fit, to pass the following as an ordinary resolution:

 

The Directors be and are hereby generally and unconditionally authorised, pursuant to Section 1021 of the Companies Act 2014, to exercise all of the powers of the Company to allot and issue all relevant securities of the Company (within the meaning of Section 1021 of the Companies Act 2014) up to an aggregate nominal amount of €75,024,756 representing 33% of the aggregate nominal value of the issued share capital of the Company as at 8 March 2016 (excluding treasury shares). The authority hereby conferred shall commence at the time of the passing of this Resolution and shall expire at the conclusion of the next Annual General Meeting of the Company after the passing of this Resolution or the date which is 15 calendar months after the date of passing this Resolution (whichever is earlier) unless and to the extent that such power is renewed, revoked, or extended prior to such date; provided that the Company may before such expiry make an offer or agreement which would or might require relevant securities to be allotted after such expiry, and the Directors may allot relevant securities in pursuance of such an offer or agreement as if the power conferred by this Resolution had not expired.

 

Resolution 7

To consider and, if thought fit, to pass the following as a special resolution:

 

 

Subject to and conditional upon Resolution 6 of the Notice of AGM being duly passed, pursuant to Sections 1022 and 1023(3) of the Companies Act 2014 the Directors be and are hereby empowered to allot equity securities (within the meaning of Section 1023(1) of the Companies Act 2014) for cash pursuant to the authority to allot relevant securities conferred on the Directors by Resolution 6 of this Notice of AGM as if Section 1022(1) of the Companies Act 2014 did not apply to any such allotment, such power to be effective from the time of passing of this Resolution and shall expire at the conclusion of the next Annual General Meeting of the Company after the passing of this Resolution or the date which is 15 calendar months after the date of passing this Resolution (whichever is earlier) unless and to the extent that such power is renewed, revoked, or extended prior to such date; and such power being limited to:

 

a) the allotment of equity securities in connection with any offer of securities, open for a period fixed by the Directors, by way of rights issue, open offer or other invitation to or in favour of the holders of ordinary shares and/or any persons having a right to subscribe for securities in the capital of the Company (including, without limitation, any person entitled to options under any of the Company's share option scheme or share incentive plans then in force) and subject thereto by way of placing or otherwise of any securities not taken up in such issue or offer and subject to such exclusions or other arrangements as the Directors may deem necessary or expedient in relation to legal or practical problems (including dealing with any fractional entitlements and/or arising in respect of any oversees shareholders) under the laws of, or the requirements of any regulatory body or stock exchange in, any territory; and/or

 

b) the allotment of equity securities up to a maximum aggregate nominal value of €11,367,387, which represents 5% of the issued share capital of the Company as at the close of business on 8 March 2016.

 

 

Ciarán Long

Group Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGEALLEAAXKEFF
Date   Source Headline
26th Nov 20203:30 pmRNSDirector Declaration
25th Nov 20202:22 pmRNSStabilisation Notice
18th Nov 20209:10 amRNSStabilisation Notice
3rd Nov 20207:00 amRNSTrading Statement
27th Oct 20207:00 amRNSSale of Buy To Let Loan Portfolio
12th Oct 20202:00 pmRNSDirector Declaration
29th Sep 20204:30 pmRNSAppointment of Senior Independent Director
25th Sep 202010:00 amRNSAppointment of Interim CFO
12th Aug 20204:00 pmRNSDirector/PDMR Shareholding
5th Aug 20203:00 pmRNSDirectorate Change
5th Aug 20203:00 pmRNSResult of AGM
4th Aug 20207:00 amRNSCommentary on Half-Year Report
4th Aug 20207:00 amRNSHalf-year Report
6th Jul 202012:00 pmRNSNotice of AGM
6th Jul 202012:00 pmRNSEuronext Listing Rules 6.1.82(1) & (2) Disclosure
22nd Jun 202010:00 amRNSAppointment of Chief Executive Officer
14th May 20207:00 amRNSTrading Statement
20th Mar 202012:00 pmRNSConvening of Annual General Meeting Deferred
17th Mar 20204:42 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
26th Feb 20207:00 amRNSCommentary on Annual Financial Report
26th Feb 20207:00 amRNSAnnual Financial Report
24th Feb 20204:41 pmRNSSecond Price Monitoring Extn
24th Feb 20204:37 pmRNSPrice Monitoring Extension
28th Jan 20204:00 pmRNSDirectorate Change
6th Nov 20197:00 amRNSTrading Statement
29th Oct 20194:00 pmRNSDirector Declaration
29th Oct 20193:00 pmRNSDirectorate Change
24th Oct 20192:00 pmRNSChief Executive To Step Down During 2020
2nd Oct 201910:00 amRNSDirector Declaration
26th Sep 201912:27 pmRNSStabilisation Notice
24th Sep 20193:30 pmRNSDirectorate Changes
19th Sep 20195:00 pmRNSDirector Declaration
19th Sep 201911:17 amRNSStabilisation Notice
12th Sep 20192:00 pmRNSSale of Non-Performing Loan Portfolio
3rd Sep 201911:00 amRNSDirector/PDMR Shareholding
3rd Sep 201911:00 amRNSDirector/PDMR Shareholding
6th Aug 20194:00 pmRNSDirector/PDMR Shareholding
29th Jul 201910:00 amRNSDirector/PDMR Shareholding
29th Jul 201910:00 amRNSDirector/PDMR Shareholding
26th Jul 20195:00 pmRNSHalf-year Report
25th Jul 20197:00 amRNSHalf-year Report
25th Jul 20197:00 amRNS2019 Half Year Report Commentary
30th May 20192:00 pmRNSConclusion of Tracker Enforcement Investigation
14th May 20194:30 pmRNSResult of AGM
9th May 20197:00 amRNSTrading Update
29th Mar 20193:30 pmRNSNotice of AGM
27th Feb 20197:00 amRNSAnnual Financial Report
27th Feb 20197:00 amRNS2018 Full Year Report Commentary
29th Nov 20184:00 pmRNSSecuritisation of a Non-Performing Loan Portfolio

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.